Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index

Official Title

Brief Summary

In this study; We aimed to investigate the role of pleth variability index, which is a noninvasive method, in showing fluid response in SARS-CoV-2 (COVID-19) patients, which we know is appropriate fluid management.

Status

Unknown status

Conditions

Pleth Variability Index

Interventions

Diagnostic Test: Pleth variability index

The usefulness of Pleth variability index in predicting fluid response in patients with COVID 19

Eligibility Criteria

Inclusion Criteria:

- Patients hospitalized in COVID 19 anesthesia intensive care unit

- Patients over the age of 18

Exclusion Criteria:

- Patients under the age of 18

Eligibility Gender

All

Eligibility Age

Minimum: 18 Years ~ Maximum: N/A

Countries

Turkey

Locations

Erzincan University
Erzincan, Turkey

Contacts

ILKE KUPELI
05555485632
ilkeser2004@gmail.com

Investigators

ILKE KUPELI, Principal Investigator
Dr.

NCT Number

NCT04373213

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Erzincan University

Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA